Abbott Laboratories Retained Earnings (Accumulated Deficit) 2010-2025 | ABT
Abbott Laboratories retained earnings (accumulated deficit) for the quarter ending March 31, 2025 were $47.261B, a 25.85% increase year-over-year.
- Abbott Laboratories retained earnings (accumulated deficit) for 2024 were $47.261B, a 25.85% increase from 2023.
- Abbott Laboratories retained earnings (accumulated deficit) for 2023 were $37.554B, a 6.52% increase from 2022.
- Abbott Laboratories retained earnings (accumulated deficit) for 2022 were $35.257B, a 11.83% increase from 2021.